Print PRINT
X

The EX–PRESS® Glaucoma Filtration Device

Lumenal Control Makes Predictability Standard Procedure

The EX-PRESS® Glaucoma Filtration Device is intended to reduce IOP in glaucoma patients when medication and conventional surgical treatments have failed. The device channels aqueous humor through a secure lumen (of either 50 μm or 200 μm) to a half-thickness scleral flap, creating a subconjunctival filtration bleb. This Lumenal Control means uniform filtration; uniform filtration helps to stabilize IOP during and after the procedure; and stable IOP means greater predictability.

Benefits for Everyone See more

Glaucoma surgeons who work with this device appreciate a more efficient operation, faster recovery times and fewer post-op visits than they would with trabeculectomy procedures.1

As for patients, they typically experience:

  • Significant reduction in IOP from baseline2
  • A decrease in the use of IOP-lowering medication2
  • Lower rates of post-op complications, such as hypotony and choroidal effusion, versus the trabeculectomy3
  • A faster return to near baseline visual acuity versus the trabeculectomy1
  • Fewer post-op visits versus the trabeculectomy3

Better Results by Design See more

The EX-PRESS® Glaucoma Filtration Device is smaller than a grain of rice, but its impact on glaucoma filtration is significant. That’s because it was engineered to exacting specifications that make it an efficient and effective alternative for standardizing aqueous humor flow and regulating IOP during and after implantation.

Take an up-close look at the pinpoint engineering of the EX-PRESS® Glaucoma Filtration Device.

An up-close look at the EX-PRESS® Glaucoma Filtration Device’s specifications.

Take an up-close look at the pinpoint engineering of the EX-PRESS® Glaucoma Filtration Device.

Want to Know More? See more

Click the thumbnails below to find out what your colleagues are saying about the EX-PRESS® Glaucoma Filtration Device.

2011 American Glaucoma Society Symposium

Read this Glaucoma Today supplement to find out why practitioners were praising the EX-PRESS® Glaucoma Filtration Device at the 2011 American Glaucoma Society Symposium. Also included are surgical pearls for EX-PRESS® Glaucoma Filtration Device implantation.

Glaucoma Today Supplement

This Glaucoma Today supplement includes more surgical pearls — and more praise — for the EX-PRESS® Glaucoma Filtration Device from surgeons throughout North America.

Enjoy the Benefits of Lumenal Control

Sign up and we’ll contact you right away with more information about the EX-PRESS® Glaucoma Filtration Device and other Alcon products.

*Name


*Email


*City


*State



*Zip Code:

*Hospital Affiliation


*Phone


How many filtration surgeries do
you perform a month?



Questions/Comments





*Required Field

Privacy Statement
Alcon will use this information to
respond to your request. Please
read our Privacy Policy for more
information.

I have read and agreed to the
Alcon Privacy Policy.

X
See Important Product Information for:
EX-PRESS® Glaucoma Filtration Device +

EX-PRESS® Glaucoma Filtration Device

CAUTION: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

INDICATION: The EX-PRESS® Glaucoma Filtration Device is intended to reduce intraocular pressure in glaucoma patients where medical and conventional surgical treatments have failed.

GUIDANCE REGARDING THE SELECTION OF THE APPROPRIATE VERSION: Prior clinical studies were not designed to compare between the various versions of the EX-PRESS® Glaucoma Filtration Device. The selection of the appropriate version is according to the doctor’s discretion.

CONTRAINDICATIONS: The use of this device is contraindicated if one or more of the following conditions exist:

  • Presence of ocular disease such as uveitis, ocular infection, severe dry eye, severe blepharitis.
  • Pre-existing ocular or systemic pathology that, in the opinion of the surgeon, is likely to cause postoperative complications following implantation of the device.
  • Patients diagnosed with angle closure glaucoma.

WARNINGS/PRECAUTIONS: The use of this device is contraindicated if one or more of the following conditions exist:

  • The surgeon should be familiar with the directions for use.
  • The integrity of the package should be examined prior to use and the device should not be used if the package is damaged and sterility is compromised.
  • This device is for single use only.
  • MRI of the head is permitted, however not recommended, in the first two weeks post implantation.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings, precautions, complications and adverse events.

EX-PRESS® Glaucoma Filtration Device

CAUTION: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

INDICATION: The EX-PRESS® Glaucoma Filtration Device is intended to reduce intraocular pressure in glaucoma patients where medical and conventional surgical treatments have failed.

GUIDANCE REGARDING THE SELECTION OF THE APPROPRIATE VERSION: Prior clinical studies were not designed to compare between the various versions of the EX-PRESS® Glaucoma Filtration Device. The selection of the appropriate version is according to the doctor’s discretion.

CONTRAINDICATIONS: The use of this device is contraindicated if one or more of the following conditions exist:

  • Presence of ocular disease such as uveitis, ocular infection, severe dry eye, severe blepharitis.
  • Pre-existing ocular or systemic pathology that, in the opinion of the surgeon, is likely to cause postoperative complications following implantation of the device.
  • Patients diagnosed with angle closure glaucoma.

WARNINGS/PRECAUTIONS: The use of this device is contraindicated if one or more of the following conditions exist:

  • The surgeon should be familiar with the directions for use.
  • The integrity of the package should be examined prior to use and the device should not be used if the package is damaged and sterility is compromised.
  • This device is for single use only.
  • MRI of the head is permitted, however not recommended, in the first two weeks post implantation.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings, precautions, complications and adverse events.